Biocryst Pharmaceuticals Inc government contracts
$233M obligated across 4 federal awards. 0 are still running.
Who buys from Biocryst Pharmaceuticals Inc
| Agency | Awards | Obligated |
|---|---|---|
| Office of Assistant Secretary for Preparedness and Response | 3 | $231M |
| National Institutes of Health | 1 | $2.6M |
What Biocryst Pharmaceuticals Inc sells
Its awards by NAICS code. Codes with live notices link to them.
| Industry | Awards | Obligated |
|---|---|---|
| NAICS 541710 NAICS 541710 | 1 | $205M |
| Pharmaceutical Preparation Manufacturing NAICS 325412 | 1 | $13.9M |
| NAICS 541711 NAICS 541711 | 1 | $11.9M |
| Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) NAICS 541715 | 1 | $2.6M |
Contracts ending soon
Awards that end in the next 18 months, soonest first. Expiring work is often recompeted.
None of Biocryst Pharmaceuticals Inc's awards in our records end in the next 18 months.
Largest awards
By total obligated value. Each links to its record on USAspending.gov.
| Award | Obligated | Start | End |
|---|---|---|---|
| ADVANCE DEVELOPMENT OF NEW ANTIVIRAL AGENT FOR INFLUENZA Office of Assistant Secretary for Preparedness and Response · HHSO100200700032C | $205M | Jan 3, 2007 | Apr 30, 2014 |
| PERAMIVIR (RAPIVAB 200MG/20ML (10MG/ML INJ SOLN)) Office of Assistant Secretary for Preparedness and Response · 75A50324F80012 | $13.9M | Sep 30, 2024 | Sep 29, 2025 |
| IGF::CT::IGF BIOCRYST PHARMACEUTICALS Office of Assistant Secretary for Preparedness and Response · HHSO100201500007C | $11.9M | Mar 31, 2015 | May 31, 2021 |
| COVID-19. TO MANUFACTURE AND EVALUATE THE SAFETY, EFFICACY AND TOLERABILITY OF GALIDESIVIR A BROAD SPECTRUM, ANTIVIRAL THERAPEUTIC. National Institutes of Health · 75N93020C00055 | $2.6M | Sep 1, 2020 | Sep 30, 2022 |
Similar contractors
Companies winning under the same main NAICS code.
| Contractor | Awards | Obligated |
|---|---|---|
| Lockheed Martin Corp UEI FYHNA5WC8XD7 | 5 | $16.7B |
| The Leland Stanford Junior University UEI HJD6G4D6TJY5 | 3 | $15.3B |
| Science Applications International Corporation UEI MMLKPW9JLX64 | 16 | $4.9B |
| The Johns Hopkins University Applied Physics Laboratory LLC UEI C1HBCJ9RMBV3 | 19 | $2.7B |
| Northrop Grumman Systems Corporation UEI VSBAFMDKTWL4 | 5 | $2B |
| General Dynamics Information Technology, Inc. UEI DCLWX76AVGZ4 | 6 | $724M |
Stop checking this page by hand
Matched, not listed
Describe your company once. Captivaq scores every new notice against your capabilities, locations, and set-asides.
Earlier than the RFP
Forecasts and sources sought notices surface months before the solicitation, while you can still shape the win.
A draft, not a link
For the bids worth pursuing, it reads the solicitation and drafts the response with citations back to the source.
Questions people ask
What is Biocryst Pharmaceuticals Inc's UEI?
MGXADJ6SCLJ5. The Unique Entity ID is the 12-character number SAM.gov assigns to every company that registers to do business with the federal government. It replaced the DUNS number in 2022.
How much has Biocryst Pharmaceuticals Inc won in federal contracts?
$233M obligated across 4 awards in Captivaq's records, most of it from Office of Assistant Secretary for Preparedness and Response. That covers contracts of $1M or more active since October 2023, so the full history is larger.
Which Biocryst Pharmaceuticals Inc contracts end soon?
None of its awards in our records end in the next 18 months.
Figures come from federal award records published on USAspending.gov: contracts of $1M or more active since October 2023, plus smaller awards tied to open opportunities. They are not a complete contract history; each award above links to its official record.
Captivaq is an independent service from Logesta Labs LLC and is not affiliated with or endorsed by the U.S. government or SAM.gov. The notice on the official source portal is the record that governs; confirm deadlines and amendments there.